Aprea Therapeutics
APRE
#10133
Rank
โ‚น0.75 B
Marketcap
โ‚น139.68
Share price
1.87%
Change (1 day)
-72.95%
Change (1 year)

Revenue for Aprea Therapeutics (APRE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aprea Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น415.70 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น147.92 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น202.47 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA